Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $45.73 million. The enterprise value is $40.58 million.
| Market Cap | 45.73M |
| Enterprise Value | 40.58M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 34.64 million shares outstanding. The number of shares has increased by 0.31% in one year.
| Shares Outstanding | 34.64M |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 17.92% |
| Owned by Institutions (%) | 48.10% |
| Float | 24.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.87 |
| Forward PS | 0.90 |
| PB Ratio | 1.71 |
| P/FCF Ratio | 30.79 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 27.33 |
Financial Position
The company has a current ratio of 5.52, with a Debt / Equity ratio of 1.44.
| Current Ratio | 5.52 |
| Quick Ratio | 4.53 |
| Debt / Equity | 1.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | 25.93 |
| Interest Coverage | -7.53 |
Financial Efficiency
Return on equity (ROE) is -56.40% and return on invested capital (ROIC) is -30.60%.
| Return on Equity (ROE) | -56.40% |
| Return on Assets (ROA) | -29.00% |
| Return on Capital (ROIC) | -30.60% |
| Revenue Per Employee | $207,734 |
| Profits Per Employee | -$74,258 |
| Employee Count | 252 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | -2.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.25% in the last 52 weeks. The beta is 1.13, so Apyx Medical's price volatility has been higher than the market average.
| Beta (1Y) | 1.13 |
| 52-Week Price Change | -55.25% |
| 50-Day Moving Average | 1.80 |
| 200-Day Moving Average | 2.94 |
| Relative Strength Index (RSI) | 39.04 |
| Average Volume (30 Days) | 157,783 |
Short Selling Information
The latest short interest is 706,675, so 2.04% of the outstanding shares have been sold short.
| Short Interest | 706,675 |
| Short Previous Month | 1.57M |
| Short % of Shares Out | 2.04% |
| Short % of Float | 2.83% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $52.35 million and -$18.71 million in losses. Loss per share was -$0.54.
| Revenue | 52.35M |
| Gross Profit | 33.76M |
| Operating Income | -19.95M |
| Pretax Income | -21.15M |
| Net Income | -18.71M |
| EBITDA | -17.89M |
| EBIT | -18.67M |
| Loss Per Share | -$0.54 |
Balance Sheet
The company has $43.65 million in cash and $38.50 million in debt, giving a net cash position of $5.15 million or $0.15 per share.
| Cash & Cash Equivalents | 43.65M |
| Total Debt | 38.50M |
| Net Cash | 5.15M |
| Net Cash Per Share | $0.15 |
| Equity / Book Value | 26.70M |
| Book Value Per Share | 0.77 |
| Working Capital | 57.62M |
Cash Flow
In the last 12 months, operating cash flow was -$5.25 million and capital expenditures $6.73 million, giving a free cash flow of $1.49 million.
| Operating Cash Flow | -5.25M |
| Capital Expenditures | 6.73M |
| Free Cash Flow | 1.49M |
| FCF Per Share | $0.04 |
Margins
Gross margin is 64.49%, with operating and profit margins of -38.11% and -35.75%.
| Gross Margin | 64.49% |
| Operating Margin | -38.11% |
| Pretax Margin | -40.39% |
| Profit Margin | -35.75% |
| EBITDA Margin | -34.17% |
| EBIT Margin | -35.66% |
| FCF Margin | 2.84% |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.31% |
| Shareholder Yield | -0.31% |
| Earnings Yield | -40.92% |
| FCF Yield | 3.25% |
Analyst Forecast
The average price target for Apyx Medical is $6.17, which is 367.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.17 |
| Price Target Difference | 367.42% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 21.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Apyx Medical has an Altman Z-Score of 0.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.32 |
| Piotroski F-Score | 3 |